Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (91-100 of 570) with videos related to

Pageof 57
Sort By:
Clinical Epigenetics|January 12, 2020
KMT2C/D COMPASS complex-associated diseases [K<sub>CD</sub>COM-ADs]: an emerging class of congenital regulopathiesWilliam J Lavery, Artem Barski, Susan Wiley, et al.
ACS Chemical Neuroscience|February 18, 2014
M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapsesTristano Pancani, Caroline Bolarinwa, Yoland Smith, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsidUpul D Halambage, Jason P Wong, Bruce J Melancon, et al.
Current Topics in Medicinal Chemistry|August 19, 2007
Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitorsCraig W Lindsley, Stanley F Barnett, Melissa Yaroschak, et al.
American Journal of Medical Genetics. Part A|October 27, 2019
Prenatal and perinatal history in Kabuki SyndromeChen E Rosenberg, Tara Daly, Christina Hung, et al.
Neuropharmacology|January 10, 2022
The effects of predator odor (TMT) exposure and mGlu<sub>3</sub> NAM pretreatment on behavioral and NMDA receptor adaptations in the brainRyan E Tyler, Maya N Bluitt, Julie L Engers, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2011
Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's diseaseZixiu Xiang, Analisa D Thompson, Carrie K Jones, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic TherapyDaniel E Jeffries, Corina M Borza, Anna L Blobaum, et al.
Journal of Clinical Immunology|September 11, 2014
Combined immune deficiency in a patient with a novel NFKB2 mutationAndrew W Lindsley, Yaping Qian, C Alexander Valencia, et al.
American Journal of Physiology. Renal Physiology|December 15, 2015
ROMK inhibitor actions in the nephron probed with diureticsSujay V Kharade, Daniel Flores, Craig W Lindsley, et al.
Pageof 57

Showing results (91-100 of 570) with videos related to

Sort By:
Pageof 57
Clinical Epigenetics|January 12, 2020
KMT2C/D COMPASS complex-associated diseases [K<sub>CD</sub>COM-ADs]: an emerging class of congenital regulopathiesWilliam J Lavery, Artem Barski, Susan Wiley, et al.
ACS Chemical Neuroscience|February 18, 2014
M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapsesTristano Pancani, Caroline Bolarinwa, Yoland Smith, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2015
Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsidUpul D Halambage, Jason P Wong, Bruce J Melancon, et al.
Current Topics in Medicinal Chemistry|August 19, 2007
Recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitorsCraig W Lindsley, Stanley F Barnett, Melissa Yaroschak, et al.
American Journal of Medical Genetics. Part A|October 27, 2019
Prenatal and perinatal history in Kabuki SyndromeChen E Rosenberg, Tara Daly, Christina Hung, et al.
Neuropharmacology|January 10, 2022
The effects of predator odor (TMT) exposure and mGlu<sub>3</sub> NAM pretreatment on behavioral and NMDA receptor adaptations in the brainRyan E Tyler, Maya N Bluitt, Julie L Engers, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 3, 2011
Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's diseaseZixiu Xiang, Analisa D Thompson, Carrie K Jones, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic TherapyDaniel E Jeffries, Corina M Borza, Anna L Blobaum, et al.
Journal of Clinical Immunology|September 11, 2014
Combined immune deficiency in a patient with a novel NFKB2 mutationAndrew W Lindsley, Yaping Qian, C Alexander Valencia, et al.
American Journal of Physiology. Renal Physiology|December 15, 2015
ROMK inhibitor actions in the nephron probed with diureticsSujay V Kharade, Daniel Flores, Craig W Lindsley, et al.
Pageof 57